(Q33999449)

30 July 2017

1 reference

title

Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy (English)

1 reference

30 July 2017

1 reference

Cloyd JC

1

1 reference

30 July 2017

Remmel RP

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

8 Pt 2

1 reference

30 July 2017

page(s)

139S-151S

1 reference

Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Clinical pharmacokinetics of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Concise review of the cytochrome P450s and their roles in toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Cytochrome P450 isozymes and antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Clinical pharmacokinetics of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

The effect of aspirin on valproic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Clinical pharmacology and pharmacokinetics of oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Surgery for catastrophic localization-related epilepsy in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.139S.35255

10.1592/PHCO.20.12.139S.35255

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference